News
Company will collaborate with German biopharma firm DeveloGen
Forthcoming stakeholder workshops could shape future direction
Biologic ingredients outstripping chemical counterparts two to three fold
Investment at Roche, Genzyme and Aeras, P&G's warning letter and Takeda's restructuring